uric acid has been researched along with Dyslipidemias in 84 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients (N = 100) with mixed dyslipidemia on a standard statin dose (10-40 mg simvastatin or 10-20 mg atorvastatin or 5-10 mg rosuvastatin) who had not achieved lipid targets were randomized to switch to the highest dose of rosuvastatin (40 mg/day) or to add-on-statin extended release nicotinic acid (ER-NA)/laropiprant (LRPT) (1000/20 mg/day for the first 4 weeks followed by 2000/40 mg/day for the next 8 weeks) or to add-on-statin micronized fenofibrate (200 mg/day) for a total of 3 months." | 9.19 | Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia. ( Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A, 2014) |
| "This study aimed to investigate the association of serum uric acid (SUA) levels with dyslipidemia and its components and to further explore the age- and gender-specific association of SUA levels with dyslipidemia in Chinese adults." | 9.05 | Association between serum uric acid levels and dyslipidemia in Chinese adults: A cross-sectional study and further meta-analysis. ( Chen, S; Chen, Y; Miao, M; Wang, J; Xu, C; Xu, L; Yang, H, 2020) |
| "Data on the relationship of baseline serum uric acid (SUA) with development of low-density lipoprotein cholesterol (LDL-C) level in patients with first acute myocardial infarction (AMI) are limited." | 8.02 | Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction. ( Chen, Y; Dai, C; Ding, C; Hu, L; Liao, H; Liao, Y; Ruan, Y; Xia, Y; Yang, R; Zhao, Y; Zou, K, 2021) |
| "This study assessed temporal relationships of serum uric acid (SUA) with blood glucose and determine the mediating effects of body mass index (BMI) and dyslipidemia on the relation of SUA and risk of type 2 diabetes." | 8.02 | Mediating Effect of Body Mass Index and Dyslipidemia on the Relation of Uric Acid and Type 2 Diabetes: Results From China Health and Retirement Longitudinal Study. ( Cheng, F; Jia, H; Li, Y; Tian, L; Zheng, H, 2021) |
| "Despite the growing pieces of evidence linking hyperuricemia with metabolic syndrome and cardiovascular disease, the relationship between dyslipidemia and serum uric acid has not yet been established." | 7.96 | Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017. ( Seo, J; Son, M; Yang, S, 2020) |
| " Our study was to discover different lipid levels of gout and asymptomatic hyperuricemia and the predictors of sUA (serum uric acid) levels." | 7.96 | The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study. ( Gu, J; Huang, Y; Jiang, Y; Li, X; Liang, J; Ou, J; Song, W; Wei, Q, 2020) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 7.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| "Hyperuricemia has been described as associated with the risk of development metabolic syndrome; however the relationship between the uric acid level and particular parameters of metabolic syndrome remained unclear." | 7.85 | Correlation of uric acid levels and parameters of metabolic syndrome. ( Cibičková, Ľ; Karásek, D; Kubíčková, V; Langová, K; Vaverková, H, 2017) |
| "Objective To explore the possible correlation between uric acid levels and leukoaraiosis (LA)." | 7.85 | The association of uric acid with leukoaraiosis. ( Cai, RW; Chen, YF; Huang, YH; Li, JJ; Li, MM; Lin, YY, 2017) |
| "To explore the association between serum uric acid (SUA) levels, metabolic syndrome (MetS) and cardiovascular disease (CVD) in patients treated with lipid-lowering agents from multiple centers in China." | 7.81 | The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. ( Chen, K; Fang, Y; Hu, D; Mu, Y; Nie, Y; Tian, Y; Wang, H; Xie, Z, 2015) |
| "Ursodeoxycholic acid (UDCA) is currently the only available pharmacological treatment for asymptomatic primary biliary cirrhosis (aPBC)." | 7.79 | Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. ( Dohmen, K; Haruno, M; Tanaka, H, 2013) |
| "To study the relationship of dyslipidemia and serum uric acid with the risk of myocardial infarction among the hypertensive type 2 diabetic and non-diabetic patients of Trinidad." | 7.77 | Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad. ( Evernden, K; Fane, U; Fatt, LA; Maharaj, D; Maharaj, N; Maharaj, S; Maharaj, SS; Maharaj, V; Maloney, V; Nayak, BS, 2011) |
| "High serum uric acid may be often associated with metabolic syndrome in Japanese people, which accelerates the development of cardiovascular disease from metabolic syndrome." | 7.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 7.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| "The purpose of this study was to assess whether increasing serum uric acid (UA) levels are related to cardiovascular disease (CVD) mortality, all-cause mortality, and incident (fatal and nonfatal) myocardial infarction (MI) in men from the general population taking into account C-reactive protein (CRP), a sensitive marker of systemic inflammation." | 7.74 | Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. ( Baumert, J; Döring, A; Koenig, W; Meisinger, C, 2008) |
| "Phthalimide derivatives have been extensively researched with various biological actions." | 5.72 | Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance. ( da Rocha, IG; da Silva Júnior, JG; da Silva Neto, JC; de Araújo, HDA; de Menezes Lima, VL; de Oliveira Assis, SP; Oliveira, RN, 2022) |
| " Compared with baseline, all 3-month treatments significantly reduce body weight and subcutaneous fat area, but only TRE and combination treatment reduce visceral fat area (VFA), fasting blood glucose, uric acid (UA), and dyslipidemia." | 5.51 | Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial. ( Chen, H; Chen, Z; Deji, C; Geng, H; Guo, H; Guo, X; He, M; Hui, CC; Li, M; Liang, Q; Liu, Y; Ma, M; Qian, B; Rensen, PCN; Shi, B; Su, S; Sui, J; Wang, J; Wang, Y; Wang, YW; Zhang, M; Zheng, Y; Zhou, WX; Zhu, WZ, 2022) |
| " Patients (N = 100) with mixed dyslipidemia on a standard statin dose (10-40 mg simvastatin or 10-20 mg atorvastatin or 5-10 mg rosuvastatin) who had not achieved lipid targets were randomized to switch to the highest dose of rosuvastatin (40 mg/day) or to add-on-statin extended release nicotinic acid (ER-NA)/laropiprant (LRPT) (1000/20 mg/day for the first 4 weeks followed by 2000/40 mg/day for the next 8 weeks) or to add-on-statin micronized fenofibrate (200 mg/day) for a total of 3 months." | 5.19 | Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia. ( Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A, 2014) |
| "We assessed the additive effect of dual peroxisome proliferators activated receptors (PPAR) alpha/gamma induction, achieved by the addition of fenofibrate to rosiglitazone, on metabolic control and diabetic dyslipidemia." | 5.12 | The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients. ( Altuntas, Y; Basat, O; Seber, S; Ucak, S, 2006) |
| "This study aimed to investigate the association of serum uric acid (SUA) levels with dyslipidemia and its components and to further explore the age- and gender-specific association of SUA levels with dyslipidemia in Chinese adults." | 5.05 | Association between serum uric acid levels and dyslipidemia in Chinese adults: A cross-sectional study and further meta-analysis. ( Chen, S; Chen, Y; Miao, M; Wang, J; Xu, C; Xu, L; Yang, H, 2020) |
| " The current obesity epidemic has in fact made it relatively frequent even among children and adolescents to find some cardiovascular risk factors known in adults such as arterial hypertension, dyslipidemia, glucose metabolism disorders and increased of uric acid values." | 5.01 | Prevention of Cardiovascular Diseases in Children and Adolescents. ( Battaglino, MG; Genovesi, S; Giussani, M; Nava, E; Orlando, A; Parati, G, 2019) |
| "The aims of this study were to evaluate the association between hypouricemia and cardiometabolic diseases, such as hypertension, dyslipidemia, and reduced kidney function, and to explore the sex-specific optimal range for serum uric acid (sUA) associated with the lowest risk for these diseases." | 4.31 | The Association Between Hypouricemia and Cardiometabolic Diseases: Analyzing Nationwide Data From Medical Checkup and Health Insurance Records. ( Kawakami, K; Koto, R; Kuwabara, M; Sato, I; Seki, T, 2023) |
| "Children in the dyslipidemia group had more severe clinical characteristics (higher blood urea nitrogen, serum uric acid, and 24-h proteinuria; higher proportion of hypertension; and lower serum albumin and estimated glomerular filtration rate) and pathological changes (higher proportion of Lee grades IV-V and E1, S1, and C2 in MEST-C)." | 4.12 | Dyslipidemia may be a risk factor for progression in children with IgA nephropathy. ( Chen, L; Jiang, M; Jiang, X; Lin, Z; Xu, Y; Zeng, S; Zhuang, H, 2022) |
| "Data on the relationship of baseline serum uric acid (SUA) with development of low-density lipoprotein cholesterol (LDL-C) level in patients with first acute myocardial infarction (AMI) are limited." | 4.02 | Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction. ( Chen, Y; Dai, C; Ding, C; Hu, L; Liao, H; Liao, Y; Ruan, Y; Xia, Y; Yang, R; Zhao, Y; Zou, K, 2021) |
| "This study assessed temporal relationships of serum uric acid (SUA) with blood glucose and determine the mediating effects of body mass index (BMI) and dyslipidemia on the relation of SUA and risk of type 2 diabetes." | 4.02 | Mediating Effect of Body Mass Index and Dyslipidemia on the Relation of Uric Acid and Type 2 Diabetes: Results From China Health and Retirement Longitudinal Study. ( Cheng, F; Jia, H; Li, Y; Tian, L; Zheng, H, 2021) |
| "To explore whether dyslipidemia, hyperglycemia or hypertension has mediating effect on the association between serum uric acid (SUA) and the development of chronic kidney disease (CKD)." | 4.02 | The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Chronic Kidney Disease in Chinese Middle-Aged and Older Population: A Mediation Analysis. ( Liu, L; Lv, X; Song, Y; Sun, H; Wang, S; Xu, L; Zhan, S, 2021) |
| " Our study was to discover different lipid levels of gout and asymptomatic hyperuricemia and the predictors of sUA (serum uric acid) levels." | 3.96 | The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study. ( Gu, J; Huang, Y; Jiang, Y; Li, X; Liang, J; Ou, J; Song, W; Wei, Q, 2020) |
| "Despite the growing pieces of evidence linking hyperuricemia with metabolic syndrome and cardiovascular disease, the relationship between dyslipidemia and serum uric acid has not yet been established." | 3.96 | Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017. ( Seo, J; Son, M; Yang, S, 2020) |
| "The urate oxidase (Uox) gene encodes uricase that in the rodent liver degrades uric acid into allantoin, forming an obstacle for establishing stable mouse models of hyperuricemia." | 3.88 | Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders. ( Cheng, X; Cui, L; Hou, X; Jia, Z; Li, C; Li, X; Liu, Z; Lu, J; Ma, L; Mi, QS; Ren, W; Sun, R; Tian, Z; Wang, C; Wang, X; Xin, Y; Yuan, X; Zhang, K, 2018) |
| " We included 1416 subjects with complete data including serum uric acid and medical history to analyze the prevalence of hyperuricemia and correlated factors." | 3.88 | The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China. ( Chen, X; Diao, Y; Feng, J; Langtai, Z; Liao, H; Meng, Q; Renqian, L; Shi, D; Shi, R; Zhang, X, 2018) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 3.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| "Subjects included 633 Japanese subjects not receiving medication for hyperuricemia, diabetes mellitus, dyslipidemia, or chronic renal disease who underwent an annual health examination that included determination of small, dense low-density lipoprotein cholesterol (sdLDL-C) and malondialdehyde-modified low-density lipoprotein (MDA-LDL) levels." | 3.88 | Low-density Lipoprotein Subclasses are Associated with Serum Uric Acid Levels. ( Moriyama, K, 2018) |
| "Objective To explore the possible correlation between uric acid levels and leukoaraiosis (LA)." | 3.85 | The association of uric acid with leukoaraiosis. ( Cai, RW; Chen, YF; Huang, YH; Li, JJ; Li, MM; Lin, YY, 2017) |
| "Hyperuricemia has been described as associated with the risk of development metabolic syndrome; however the relationship between the uric acid level and particular parameters of metabolic syndrome remained unclear." | 3.85 | Correlation of uric acid levels and parameters of metabolic syndrome. ( Cibičková, Ľ; Karásek, D; Kubíčková, V; Langová, K; Vaverková, H, 2017) |
| "At high altitude, increased γGT levels were associated with hyperglycemia; increased uric acid levels were associated with overweight/obesity, hemoglobin, dyslipidemia, high blood pressure and kidney disease." | 3.81 | Increased levels of serum γ-glutamyltransferase and uric acid on metabolic, hepatic and kidney parameters in subjects at high altitudes. ( Gonzales, GF; Tapia, V, 2015) |
| "To explore the association between serum uric acid (SUA) levels, metabolic syndrome (MetS) and cardiovascular disease (CVD) in patients treated with lipid-lowering agents from multiple centers in China." | 3.81 | The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. ( Chen, K; Fang, Y; Hu, D; Mu, Y; Nie, Y; Tian, Y; Wang, H; Xie, Z, 2015) |
| "Ursodeoxycholic acid (UDCA) is currently the only available pharmacological treatment for asymptomatic primary biliary cirrhosis (aPBC)." | 3.79 | Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. ( Dohmen, K; Haruno, M; Tanaka, H, 2013) |
| "The objective of this study was to explore the relationships between circulating uric acid and lipid levels and components of the metabolic syndrome (MetS) in Arab dyslipidemic patients, a group already at high coronary artery disease risk." | 3.78 | Determinants of blood uric acid levels in a dyslipidemic Arab population. ( Akanji, AO; Al-Meshaweh, AF; Asem, M; Jafar, Y, 2012) |
| " Obesity was not associated with differences in composition, although a secondary analysis of morbidly obese patients showed a higher proportion of uric acid stones and a lower proportion of calcium oxalate stones." | 3.78 | Metabolic syndrome and urinary stone composition: what factors matter most? ( Fridirici, ZC; Greco, K; Hart, ST; Kadlec, AO; Turk, TM; Vellos, T, 2012) |
| " Univariate logistic regression analysis revealed a significant association between the onset of CKD and age, male gender, body mass index, blood pressure, fasting plasma glucose, dyslipidemia and uric acid." | 3.77 | Uric acid levels predict future development of chronic kidney disease. ( Dohi, Y; Kimura, G; Sonoda, H; Takase, H, 2011) |
| "To study the relationship of dyslipidemia and serum uric acid with the risk of myocardial infarction among the hypertensive type 2 diabetic and non-diabetic patients of Trinidad." | 3.77 | Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad. ( Evernden, K; Fane, U; Fatt, LA; Maharaj, D; Maharaj, N; Maharaj, S; Maharaj, SS; Maharaj, V; Maloney, V; Nayak, BS, 2011) |
| " It specifically addressed the hypotheses that renal dysfunction in these patients may associate with the presence of insulin resistance, dyslipidaemia, uric acid levels and/or current levels of systemic inflammation." | 3.76 | Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. ( Antonopoulos, I; Daoussis, D; Douglas, KM; John, H; Kitas, GD; Nightingale, P; Panoulas, VF; Toms, TE; Wong, P, 2010) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 3.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| "High serum uric acid may be often associated with metabolic syndrome in Japanese people, which accelerates the development of cardiovascular disease from metabolic syndrome." | 3.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "The purpose of this study was to assess whether increasing serum uric acid (UA) levels are related to cardiovascular disease (CVD) mortality, all-cause mortality, and incident (fatal and nonfatal) myocardial infarction (MI) in men from the general population taking into account C-reactive protein (CRP), a sensitive marker of systemic inflammation." | 3.74 | Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. ( Baumert, J; Döring, A; Koenig, W; Meisinger, C, 2008) |
| "However, all patients with lupus nephritis have by definition chronic kidney disease (CKD) as they will have proteinuria with varying degrees of renal impairment." | 2.49 | Renoprotective strategies in lupus nephritis: beyond immunosuppression. ( Griffin, B; Lightstone, L, 2013) |
| "Dyslipidemia is the most common risk factor for cardiovascular disease, causing more than 4 million deaths each year worldwide." | 1.91 | Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia. ( Addisu, B; Bekele, S; Cheneke, W; Hirigo, AT; Wube, TB, 2023) |
| "Asymptomatic hyperuricemia is prevalent among young adults and associated with markers of prediabetes, dyslipidemia, and subclinical inflammation." | 1.72 | Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar. ( Al Shanableh, Y; Al-Mansoori, A; Al-Mohannadi, M; Aljalham, B; Hussein, YY; Nurulhoque, H; Robelah, F; Saidwali, AH; Zughaier, SM, 2022) |
| "The association between serum uric acid (SUA) and the components of dyslipidaemia and their dose-response relationships have not been thoroughly explored." | 1.72 | The dose-response relationship of serum uric acid with Dyslipidaemia and its components: a cross-sectional study of a Chinese multi-ethnic cohort. ( Hong, F; Liu, L; Ma, L; Ma, N; Nie, C; Peng, L; Wang, Z; Xu, D; Xu, Y; Yang, F; Yang, T; Zeng, Q, 2022) |
| "Phthalimide derivatives have been extensively researched with various biological actions." | 1.72 | Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance. ( da Rocha, IG; da Silva Júnior, JG; da Silva Neto, JC; de Araújo, HDA; de Menezes Lima, VL; de Oliveira Assis, SP; Oliveira, RN, 2022) |
| " There was a nonlinear dose-response between TG, HDL-C, and serum uric acid (SUA)." | 1.72 | Association between dyslipidaemia and the risk of hyperuricaemia: a six-year longitudinal cohort study of elderly individuals in China. ( Dong, H; Ma, Q; Sun, H; Xu, Y; Zhang, B; Zhang, J, 2022) |
| "Gout has significant impact on the quality of life with over-utilisation of health resources." | 1.56 | Burden and management of gout in a multi-ethnic Asian cohort. ( Cheung, PP; Chua, CKT; Lim, AYN; Santosa, A; Teng, GG, 2020) |
| "Obesity is a risk factor for hypertension, diabetes mellitus (DM), dyslipidemia, and hyperuricemia." | 1.48 | Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. ( Hisatome, I; Jalal, DI; Johnson, RJ; Kuwabara, M; Kuwabara, R; Lanaspa, MA; MacLean, PS; Niwa, K; Ohno, M; Roncal-Jimenez, CA; Smits, G; Yracheta, JM, 2018) |
| "123 participants who had NAFLD at baseline lost NAFLD during the 8-year follow-up period." | 1.43 | Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. ( Chen, XH; Li, YL; Lu, ZY; Shao, Z; Wulasihan, M, 2016) |
| "Hyperuricemia was defined as serum uric acid ≥416 μmol/l in men and ≥357 μmol/l in women." | 1.43 | Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. ( Guo, X; Ou, Q; Sun, Y; Yang, H; Yu, S; Zhang, X; Zheng, L; Zhou, Y, 2016) |
| "Insulin resistance is associated with inadequate body composition, in biochemical levels and lifestyle, being the factors associated different in each phase of adolescence." | 1.40 | [Insulin resistance and components of metabolic syndrome, analysis by gender and stage of adolescence]. ( Faria, ER; Faria, FR; Franceschini, Sdo C; Novaes, JF; Peluzio, Mdo C; Priore, SE; Ribeiro, AQ; Ribeiro, SM; Sant Ana, LF, 2014) |
| "Uric acid level was significantly different between women with and without increased arterial stiffness, but not in men." | 1.40 | High uric acid level associated with increased arterial stiffness in apparently healthy women. ( Chang, CJ; Fang, JI; Lu, FH; Wang, RH; Wu, JS; Yang, YC, 2014) |
| "The metabolic syndrome was defined based on the criteria of the Chinese Diabetes Society (CDS)." | 1.36 | The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. ( Chen, B; Chen, Y; Ni, Z; Xu, W; Yang, D; Ye, B, 2010) |
| "A total of 102 type 2 diabetes mellitus patients were divided into 2 groups: DR group (age, 60 +/- 6 years [mean +/- SD]; n = 31) and no diabetic retinopathy (NDR) group (59 +/- 5 years, n = 71)." | 1.36 | Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. ( Anan, F; Eshima, N; Eto, T; Ito, Y; Masaki, T; Saikawa, T; Umeno, Y; Yoshimatsu, H, 2010) |
| "The prevalence of hyperuricemia is low in Uygurs, who have a high prevalence of cardiovascular risk factors such as hypertension, overweight-obesity, dyslipidemia, hyperglycemia, and insulin resistance (IR)." | 1.35 | Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population. ( Hong, J; Li, NF; Wang, HM; Yang, J; Yao, XG; Zhou, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (8.33) | 29.6817 |
| 2010's | 53 (63.10) | 24.3611 |
| 2020's | 24 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, JF | 1 |
| Shoenfeld, Y | 1 |
| Chen, Y | 3 |
| Ding, C | 1 |
| Hu, L | 1 |
| Ruan, Y | 1 |
| Zou, K | 1 |
| Dai, C | 1 |
| Liao, Y | 1 |
| Liao, H | 2 |
| Xia, Y | 1 |
| Zhao, Y | 2 |
| Yang, R | 1 |
| Al Shanableh, Y | 1 |
| Hussein, YY | 1 |
| Saidwali, AH | 1 |
| Al-Mohannadi, M | 1 |
| Aljalham, B | 1 |
| Nurulhoque, H | 1 |
| Robelah, F | 1 |
| Al-Mansoori, A | 1 |
| Zughaier, SM | 1 |
| Cheng, F | 1 |
| Li, Y | 2 |
| Zheng, H | 1 |
| Tian, L | 1 |
| Jia, H | 1 |
| Zhuang, H | 1 |
| Lin, Z | 1 |
| Zeng, S | 1 |
| Jiang, M | 2 |
| Chen, L | 2 |
| Jiang, X | 1 |
| Xu, Y | 4 |
| Peng, L | 1 |
| Liu, L | 2 |
| Ma, N | 1 |
| Yang, F | 1 |
| Nie, C | 1 |
| Yang, T | 1 |
| Zeng, Q | 1 |
| Wang, Z | 2 |
| Xu, D | 1 |
| Ma, L | 2 |
| Hong, F | 1 |
| Dong, H | 1 |
| Zhang, B | 1 |
| Zhang, J | 2 |
| Ma, Q | 1 |
| Sun, H | 2 |
| da Silva Júnior, JG | 1 |
| de Araújo, HDA | 1 |
| da Rocha, IG | 1 |
| da Silva Neto, JC | 1 |
| Oliveira, RN | 1 |
| de Oliveira Assis, SP | 1 |
| de Menezes Lima, VL | 1 |
| Koto, R | 1 |
| Sato, I | 1 |
| Kuwabara, M | 2 |
| Seki, T | 1 |
| Kawakami, K | 1 |
| He, M | 1 |
| Wang, J | 2 |
| Liang, Q | 1 |
| Li, M | 1 |
| Guo, H | 1 |
| Wang, Y | 2 |
| Deji, C | 1 |
| Sui, J | 1 |
| Wang, YW | 1 |
| Liu, Y | 2 |
| Zheng, Y | 1 |
| Qian, B | 1 |
| Chen, H | 1 |
| Ma, M | 1 |
| Su, S | 1 |
| Geng, H | 1 |
| Zhou, WX | 1 |
| Guo, X | 5 |
| Zhu, WZ | 1 |
| Zhang, M | 1 |
| Chen, Z | 1 |
| Rensen, PCN | 1 |
| Hui, CC | 1 |
| Shi, B | 1 |
| Liu, J | 1 |
| Pan, H | 1 |
| Guan, M | 1 |
| Li, X | 3 |
| Chen, S | 3 |
| Tong, X | 1 |
| Luo, Y | 1 |
| Wang, X | 2 |
| Yang, X | 2 |
| Tao, L | 1 |
| Yu, J | 1 |
| Liu, X | 1 |
| Ji, H | 1 |
| Zhang, Y | 1 |
| Zhan, H | 1 |
| Zhang, Z | 1 |
| Wen, J | 1 |
| Addisu, B | 1 |
| Bekele, S | 1 |
| Wube, TB | 1 |
| Hirigo, AT | 1 |
| Cheneke, W | 1 |
| Chua, CKT | 1 |
| Cheung, PP | 1 |
| Santosa, A | 1 |
| Lim, AYN | 1 |
| Teng, GG | 1 |
| Li, L | 1 |
| Song, Q | 1 |
| Chiu, S | 1 |
| Siri-Tarino, P | 1 |
| Bergeron, N | 1 |
| Suh, JH | 1 |
| Krauss, RM | 1 |
| Son, M | 1 |
| Seo, J | 1 |
| Yang, S | 1 |
| Liang, J | 1 |
| Jiang, Y | 1 |
| Huang, Y | 2 |
| Song, W | 1 |
| Ou, J | 1 |
| Wei, Q | 1 |
| Gu, J | 1 |
| Yang, H | 4 |
| Xu, L | 2 |
| Miao, M | 1 |
| Xu, C | 1 |
| Patel, PM | 1 |
| Kandabarow, AM | 1 |
| Druck, A | 1 |
| Hart, S | 1 |
| Blackwell, RH | 1 |
| Kadlec, A | 1 |
| Farooq, A | 1 |
| Turk, TMT | 1 |
| Baldea, KG | 1 |
| Suzuki, K | 1 |
| Gonda, K | 1 |
| Kishimoto, Y | 1 |
| Katsumoto, Y | 1 |
| Takenoshita, S | 1 |
| Liu, H | 1 |
| Zhuang, J | 1 |
| Tang, P | 1 |
| Li, J | 1 |
| Xiong, X | 1 |
| Deng, H | 1 |
| Yu, X | 1 |
| Wang, T | 1 |
| Huang, S | 1 |
| Zeng, P | 1 |
| Adeyanju, OA | 1 |
| Badejogbin, OC | 1 |
| Areola, DE | 1 |
| Olaniyi, KS | 1 |
| Dibia, C | 1 |
| Soetan, OA | 1 |
| Oniyide, AA | 1 |
| Michael, OS | 1 |
| Olatunji, LA | 1 |
| Soladoye, AO | 1 |
| Zhan, S | 1 |
| Wang, S | 1 |
| Lv, X | 1 |
| Song, Y | 1 |
| Lu, J | 1 |
| Hou, X | 1 |
| Yuan, X | 1 |
| Cui, L | 1 |
| Liu, Z | 1 |
| Cheng, X | 1 |
| Xin, Y | 1 |
| Wang, C | 1 |
| Zhang, K | 1 |
| Ren, W | 1 |
| Sun, R | 1 |
| Jia, Z | 1 |
| Tian, Z | 1 |
| Mi, QS | 1 |
| Li, C | 1 |
| Latourte, A | 1 |
| Bardin, T | 1 |
| Clerson, P | 1 |
| Ea, HK | 1 |
| Flipo, RM | 1 |
| Richette, P | 1 |
| Mahbub, MH | 1 |
| Yamaguchi, N | 1 |
| Takahashi, H | 1 |
| Hase, R | 1 |
| Ishimaru, Y | 1 |
| Sunagawa, H | 1 |
| Amano, H | 1 |
| Kobayashi-Miura, M | 1 |
| Kanda, H | 1 |
| Fujita, Y | 1 |
| Yamamoto, H | 1 |
| Yamamoto, M | 1 |
| Kikuchi, S | 1 |
| Ikeda, A | 1 |
| Kageyama, N | 1 |
| Nakamura, M | 1 |
| Tanabe, T | 1 |
| Srećković, B | 1 |
| Soldatovic, I | 1 |
| Colak, E | 1 |
| Mrdovic, I | 1 |
| Sumarac-Dumanovic, M | 1 |
| Janeski, H | 1 |
| Janeski, N | 1 |
| Gacic, J | 1 |
| Dimitrijevic-Sreckovic, V | 1 |
| Kuwabara, R | 1 |
| Niwa, K | 1 |
| Hisatome, I | 1 |
| Smits, G | 1 |
| Roncal-Jimenez, CA | 1 |
| MacLean, PS | 1 |
| Yracheta, JM | 1 |
| Ohno, M | 1 |
| Lanaspa, MA | 1 |
| Johnson, RJ | 1 |
| Jalal, DI | 1 |
| Moriyama, K | 1 |
| Zhang, X | 4 |
| Meng, Q | 1 |
| Feng, J | 1 |
| Shi, R | 1 |
| Shi, D | 1 |
| Renqian, L | 1 |
| Langtai, Z | 1 |
| Diao, Y | 1 |
| Chen, X | 1 |
| Ferron, AJT | 1 |
| Francisqueti, FV | 1 |
| Minatel, IO | 1 |
| Silva, CCVA | 1 |
| Bazan, SGZ | 1 |
| Kitawara, KAH | 1 |
| Garcia, JL | 1 |
| Corrêa, CR | 1 |
| Moreto, F | 1 |
| Ferreira, ALA | 1 |
| Viazzi, F | 1 |
| Russo, GT | 1 |
| Ceriello, A | 1 |
| Fioretto, P | 1 |
| Giorda, C | 1 |
| De Cosmo, S | 1 |
| Pontremoli, R | 1 |
| Katayama, A | 1 |
| Yokokawa, H | 1 |
| Fukuda, H | 1 |
| Ono, Y | 1 |
| Isonuma, H | 1 |
| Hisaoka, T | 1 |
| Naito, T | 1 |
| Ali, N | 1 |
| Rahman, S | 1 |
| Islam, S | 1 |
| Haque, T | 1 |
| Molla, NH | 1 |
| Sumon, AH | 1 |
| Kathak, RR | 1 |
| Asaduzzaman, M | 1 |
| Islam, F | 1 |
| Mohanto, NC | 1 |
| Hasnat, MA | 1 |
| Nurunnabi, SM | 1 |
| Ahmed, S | 1 |
| Genovesi, S | 1 |
| Giussani, M | 1 |
| Orlando, A | 1 |
| Battaglino, MG | 1 |
| Nava, E | 1 |
| Parati, G | 1 |
| Griffin, B | 1 |
| Lightstone, L | 1 |
| Dohmen, K | 1 |
| Tanaka, H | 1 |
| Haruno, M | 1 |
| Juraschek, SP | 1 |
| Tunstall-Pedoe, H | 1 |
| Woodward, M | 1 |
| Kei, A | 1 |
| Tellis, C | 1 |
| Liberopoulos, E | 1 |
| Tselepis, A | 1 |
| Elisaf, M | 1 |
| Vallianou, NG | 1 |
| Evangelopoulos, AA | 1 |
| Bountziouka, V | 1 |
| Bonou, MS | 1 |
| Katsagoni, C | 1 |
| Vogiatzakis, ED | 1 |
| Avgerinos, PC | 1 |
| Barbetseas, J | 1 |
| Panagiotakos, DB | 1 |
| Gonzales, GF | 1 |
| Tapia, V | 1 |
| Fang, JI | 1 |
| Wu, JS | 1 |
| Yang, YC | 1 |
| Wang, RH | 1 |
| Lu, FH | 1 |
| Chang, CJ | 1 |
| Faria, ER | 1 |
| Faria, FR | 1 |
| Franceschini, Sdo C | 1 |
| Peluzio, Mdo C | 1 |
| Sant Ana, LF | 1 |
| Novaes, JF | 1 |
| Ribeiro, SM | 1 |
| Ribeiro, AQ | 1 |
| Priore, SE | 1 |
| Zhu, W | 1 |
| Mai, L | 1 |
| Fang, L | 1 |
| Ying, K | 1 |
| Kirejczyk, JK | 1 |
| Korzeniecka-Kozerska, A | 1 |
| Baran, M | 1 |
| Porowska, H | 1 |
| Porowski, T | 1 |
| Wasilewska, A | 1 |
| Tian, Y | 1 |
| Chen, K | 1 |
| Xie, Z | 1 |
| Fang, Y | 1 |
| Wang, H | 1 |
| Nie, Y | 1 |
| Hu, D | 1 |
| Mu, Y | 1 |
| Yu, S | 3 |
| Sun, G | 1 |
| Sun, Y | 3 |
| Lu, W | 1 |
| Shao, X | 2 |
| Gao, F | 1 |
| Hu, J | 1 |
| Zuo, Z | 1 |
| Zhou, L | 2 |
| Cen, X | 1 |
| Zhou, Y | 1 |
| Ou, Q | 1 |
| Zheng, L | 2 |
| Deedwania, PC | 1 |
| Stone, PH | 1 |
| Fayyad, RS | 1 |
| Laskey, RE | 1 |
| Wilson, DJ | 1 |
| Krittayaphong, R | 1 |
| Rangsin, R | 1 |
| Thinkhamrop, B | 1 |
| Hurst, C | 1 |
| Rattanamongkolgul, S | 1 |
| Sripaiboonkij, N | 1 |
| Yindeengam, A | 1 |
| Lu, ZY | 1 |
| Shao, Z | 1 |
| Li, YL | 1 |
| Wulasihan, M | 1 |
| Chen, XH | 1 |
| Furuhashi, M | 1 |
| Omori, A | 1 |
| Matsumoto, M | 1 |
| Kataoka, Y | 1 |
| Tanaka, M | 1 |
| Moniwa, N | 1 |
| Ohnishi, H | 1 |
| Yoshida, H | 1 |
| Saitoh, S | 1 |
| Shimamoto, K | 1 |
| Miura, T | 1 |
| Cheung, YT | 1 |
| Edelmann, MN | 1 |
| Mulrooney, DA | 1 |
| Green, DM | 1 |
| Chemaitilly, W | 1 |
| John, N | 1 |
| Robison, LL | 1 |
| Hudson, MM | 1 |
| Krull, KR | 1 |
| Sakoh, T | 1 |
| Nakayama, M | 1 |
| Tsuchihashi, T | 1 |
| Yoshitomi, R | 1 |
| Tanaka, S | 1 |
| Katafuchi, E | 1 |
| Fukui, A | 1 |
| Shikuwa, Y | 1 |
| Anzai, N | 1 |
| Kitazono, T | 1 |
| Tsuruya, K | 1 |
| Li, JJ | 1 |
| Huang, YH | 1 |
| Lin, YY | 1 |
| Li, MM | 1 |
| Chen, YF | 1 |
| Cai, RW | 1 |
| Cibičková, Ľ | 1 |
| Langová, K | 1 |
| Vaverková, H | 1 |
| Kubíčková, V | 1 |
| Karásek, D | 1 |
| Quintanilla, MA | 1 |
| Andrés, M | 1 |
| Pascual, E | 1 |
| Pallarés, V | 1 |
| Fácila, L | 1 |
| Morillas, P | 1 |
| Daoussis, D | 1 |
| Panoulas, VF | 1 |
| Antonopoulos, I | 1 |
| John, H | 1 |
| Toms, TE | 1 |
| Wong, P | 1 |
| Nightingale, P | 1 |
| Douglas, KM | 1 |
| Kitas, GD | 1 |
| Anan, F | 1 |
| Masaki, T | 1 |
| Ito, Y | 1 |
| Eto, T | 1 |
| Umeno, Y | 1 |
| Eshima, N | 1 |
| Saikawa, T | 1 |
| Yoshimatsu, H | 1 |
| Li, NF | 1 |
| Wang, HM | 1 |
| Yang, J | 1 |
| Yao, XG | 1 |
| Hong, J | 1 |
| Chen, B | 1 |
| Yang, D | 1 |
| Xu, W | 1 |
| Ye, B | 1 |
| Ni, Z | 1 |
| Hongo, M | 1 |
| Hidaka, H | 1 |
| Sakaguchi, S | 1 |
| Nakanishi, K | 1 |
| Ichikawa, M | 1 |
| Hirota, N | 1 |
| Tanaka, N | 1 |
| Tsuruta, G | 1 |
| Yazaki, Y | 1 |
| Kinoshita, O | 1 |
| Ikeda, U | 1 |
| Koike, K | 1 |
| Loomba, R | 1 |
| Rao, F | 1 |
| Zhang, L | 1 |
| Khandrika, S | 1 |
| Ziegler, MG | 1 |
| Brenner, DA | 1 |
| O'Connor, DT | 1 |
| Ogata, N | 1 |
| Fujimori, S | 1 |
| Oka, Y | 1 |
| Kaneko, K | 1 |
| Sonoda, H | 1 |
| Takase, H | 1 |
| Dohi, Y | 1 |
| Kimura, G | 1 |
| Nery, AB | 1 |
| Mesquita, ET | 1 |
| Lugon, JR | 1 |
| Kang, HC | 1 |
| de Miranda, VA | 1 |
| de Souza, BG | 1 |
| Andrade, JA | 1 |
| Rosa, ML | 1 |
| Martí del Moral, L | 1 |
| Agil, A | 1 |
| Navarro-Alarcón, M | 1 |
| López-Ga de la Serrana, H | 1 |
| Palomares-Bayo, M | 1 |
| Oliveras-López, MJ | 1 |
| Nayak, BS | 1 |
| Maharaj, N | 1 |
| Maharaj, SS | 1 |
| Evernden, K | 1 |
| Fane, U | 1 |
| Fatt, LA | 1 |
| Maharaj, D | 1 |
| Maharaj, S | 1 |
| Maharaj, V | 1 |
| Maloney, V | 1 |
| Al-Meshaweh, AF | 1 |
| Jafar, Y | 1 |
| Asem, M | 1 |
| Akanji, AO | 1 |
| Hu, QH | 1 |
| Pan, Y | 1 |
| Li, YC | 1 |
| Kong, LD | 1 |
| Zinellu, A | 1 |
| Sotgia, S | 1 |
| Pisanu, E | 1 |
| Loriga, G | 1 |
| Deiana, L | 1 |
| Satta, AE | 1 |
| Carru, C | 1 |
| Kunitskaia, NA | 1 |
| Ar'ev, AL | 1 |
| Kadlec, AO | 1 |
| Greco, K | 1 |
| Fridirici, ZC | 1 |
| Hart, ST | 1 |
| Vellos, T | 1 |
| Turk, TM | 1 |
| Baliarsingh, S | 1 |
| Sharma, N | 1 |
| Mukherjee, R | 1 |
| Seber, S | 1 |
| Ucak, S | 1 |
| Basat, O | 1 |
| Altuntas, Y | 1 |
| Agostinho Gimeno, SG | 1 |
| Rodrigues, D | 1 |
| Pagliaro, H | 1 |
| Cano, EN | 1 |
| de Souza Lima, EE | 1 |
| Baruzzi, RG | 1 |
| Kawada, T | 1 |
| Otsuka, T | 1 |
| Katsumata, M | 1 |
| Suzuki, H | 1 |
| Wallace, C | 1 |
| Newhouse, SJ | 1 |
| Braund, P | 1 |
| Zhang, F | 1 |
| Tobin, M | 1 |
| Falchi, M | 1 |
| Ahmadi, K | 1 |
| Dobson, RJ | 1 |
| Marçano, AC | 1 |
| Hajat, C | 1 |
| Burton, P | 1 |
| Deloukas, P | 1 |
| Brown, M | 1 |
| Connell, JM | 1 |
| Dominiczak, A | 1 |
| Lathrop, GM | 1 |
| Webster, J | 1 |
| Farrall, M | 1 |
| Spector, T | 1 |
| Samani, NJ | 1 |
| Caulfield, MJ | 1 |
| Munroe, PB | 1 |
| Numata, T | 1 |
| Miyatake, N | 1 |
| Wada, J | 1 |
| Makino, H | 1 |
| Meisinger, C | 1 |
| Koenig, W | 1 |
| Baumert, J | 1 |
| Döring, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Intervention Study of Intermittent Fasting and Low Carbon Diet in Patients With Metabolic Syndrome[NCT04475822] | 169 participants (Actual) | Interventional | 2020-07-12 | Completed | |||
| Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia[NCT01010516] | Phase 4 | 120 participants (Anticipated) | Interventional | 2009-10-31 | Recruiting | ||
| Study Protocol for a Prospective Observational Study Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation[NCT04017806] | 60 participants (Anticipated) | Observational | 2018-09-19 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for uric acid and Dyslipidemias
| Article | Year |
|---|---|
Association between serum uric acid levels and dyslipidemia in Chinese adults: A cross-sectional study and further meta-analysis.
Topics: Age Factors; China; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Hyperuricemia; Male; Mid | 2020 |
The Role of the Gut Microbiota in Coronary Heart Disease.
Topics: Animals; Cholesterol; Coronary Disease; Diabetes Complications; Dyslipidemias; Gastrointestinal Micr | 2020 |
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals.
Topics: Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dyslipidemias; Humans; Hypertension; | 2019 |
Prevention of Cardiovascular Diseases in Children and Adolescents.
Topics: Adolescent; Age of Onset; Arterial Pressure; Biomarkers; Blood Glucose; Cardiovascular Diseases; Chi | 2019 |
Renoprotective strategies in lupus nephritis: beyond immunosuppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Disease Progression; Dyslipidemias; Humans; | 2013 |
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Dyslipidemias; Female; Genome, Human; Humans; Lipids; Mal | 2008 |
7 trials available for uric acid and Dyslipidemias
| Article | Year |
|---|---|
Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial.
Topics: Blood Glucose; Body Weight; Diet, Carbohydrate-Restricted; Dyslipidemias; Humans; Intra-Abdominal Fa | 2022 |
A Randomized Study of the Effect of Replacing Sugar-Sweetened Soda by Reduced Fat Milk on Cardiometabolic Health in Male Adolescent Soda Drinkers.
Topics: Adolescent; Animals; Blood Pressure; Carbonated Beverages; Cardiovascular Diseases; Drinking; Dyslip | 2020 |
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combinatio | 2014 |
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
Topics: Aged; Aged, 80 and over; Atorvastatin; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Dysl | 2015 |
Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dyslipidemias; Fluorobenzenes; Heptanoic A | 2010 |
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy.
Topics: Allantoin; Apolipoproteins B; Azetidines; Cholesterol, LDL; Drug Combinations; Dyslipidemias; Ezetim | 2012 |
The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellit | 2006 |
71 other studies available for uric acid and Dyslipidemias
| Article | Year |
|---|---|
Uric acid levels in primary antiphospholipid syndrome.
Topics: Adult; Age Factors; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Synd | 2021 |
Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction.
Topics: Aged; Biomarkers; China; Cholesterol, LDL; Dyslipidemias; Female; Hospitalization; Humans; Hyperuric | 2021 |
Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar.
Topics: Adolescent; Adult; Biomarkers; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Hyperuricemia | 2022 |
Mediating Effect of Body Mass Index and Dyslipidemia on the Relation of Uric Acid and Type 2 Diabetes: Results From China Health and Retirement Longitudinal Study.
Topics: Aged; Blood Glucose; Body Mass Index; China; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Human | 2021 |
Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.
Topics: Child; Disease Progression; Dyslipidemias; Glomerular Filtration Rate; Glomerulonephritis, IGA; Huma | 2022 |
The dose-response relationship of serum uric acid with Dyslipidaemia and its components: a cross-sectional study of a Chinese multi-ethnic cohort.
Topics: Adult; Aged; China; Cohort Studies; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Male; Mi | 2022 |
Association between dyslipidaemia and the risk of hyperuricaemia: a six-year longitudinal cohort study of elderly individuals in China.
Topics: Aged; China; Cohort Studies; Dyslipidemias; Humans; Hyperuricemia; Longitudinal Studies; Prospective | 2022 |
Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance.
Topics: Animals; Carboxymethylcellulose Sodium; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dyslipidemias; | 2022 |
The Association Between Hypouricemia and Cardiometabolic Diseases: Analyzing Nationwide Data From Medical Checkup and Health Insurance Records.
Topics: Cross-Sectional Studies; Dyslipidemias; Female; Humans; Hypertension; Insurance, Health; Male; Purin | 2023 |
Distinct hyperuricemia trajectories are associated with different risks of incident diabetes: A prospective cohort study.
Topics: Adult; Diabetes Mellitus; Dyslipidemias; Humans; Hypertension; Hyperuricemia; Middle Aged; Obesity; | 2023 |
Distribution of serum uric acid concentration and its association with lipid profiles: a single-center retrospective study in children aged 3 to 12 years with adenoid and tonsillar hypertrophy.
Topics: Adenoids; Child; Dyslipidemias; Humans; Hypertrophy; Hyperuricemia; Lipids; Retrospective Studies; R | 2023 |
Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Dyslipidemias; Ethiopia; Hospi | 2023 |
Burden and management of gout in a multi-ethnic Asian cohort.
Topics: Adult; Aged; Allopurinol; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Dyslipidemias; Em | 2020 |
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes | 2019 |
Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017.
Topics: Adult; Dyslipidemias; Female; Health Surveys; Humans; Hyperuricemia; Male; Middle Aged; Republic of | 2020 |
The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Dyslipidemias; Female; Gout; Humans; Hy | 2020 |
Association of Impaired Renal Function With Changes in Urinary Mineral Excretion and Stone Composition.
Topics: Adult; Calcium; Calcium Oxalate; Calcium Phosphates; Citric Acid; Creatinine; Diabetes Mellitus; Dis | 2020 |
Potential curing and beneficial effects of Ooitabi (Ficus pumila L.) on hypertension and dyslipidaemia in Okinawa.
Topics: Blood Pressure; Dyslipidemias; Ficus; Humans; Hypertension; Uric Acid | 2021 |
Evaluation of the causal effects of blood lipid levels on gout with summary level GWAS data: two-sample Mendelian randomization and mediation analysis.
Topics: Age Factors; Causality; Cholesterol; Dyslipidemias; Genome-Wide Association Study; Gout; Humans; Hyp | 2021 |
Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats.
Topics: Animals; Blood Glucose; Butyric Acid; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Female; | 2021 |
The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Chronic Kidney Disease in Chinese Middle-Aged and Older Population: A Mediation Analysis.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Dyslipidemias; Female; Follow-Up Studies; Glomerular Fil | 2021 |
Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.
Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellit | 2018 |
Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
Topics: Aged; Alcohol Drinking; Comorbidity; Cross-Sectional Studies; Dyslipidemias; Female; France; Gout; G | 2018 |
Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome.
Topics: Adult; Aged; Amino Acids; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus; Dyslipidemi | 2017 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidem | 2018 |
Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Ind | 2018 |
Low-density Lipoprotein Subclasses are Associated with Serum Uric Acid Levels.
Topics: Adult; Aged; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Dyslipidemias; | 2018 |
The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol; Cross-Sectional Studies; Dyslipidemias; Fem | 2018 |
Association between Cardiac Remodeling and Metabolic Alteration in an Experimental Model of Obesity Induced by Western Diet.
Topics: Animals; Atrial Remodeling; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Cho | 2018 |
Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cross-Sectional Studies; Drug Monitoring; Dyslipidemias | 2019 |
The relationship between serum uric acid and lipid profile in Bangladeshi adults.
Topics: Adult; Bangladesh; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Dyslipidemias; Fema | 2019 |
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort S | 2013 |
Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus; Dyslipidemias; Female; Foll | 2014 |
Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Butyrylcholinesterase; Cross-Sectional Studies; D | 2014 |
Increased levels of serum γ-glutamyltransferase and uric acid on metabolic, hepatic and kidney parameters in subjects at high altitudes.
Topics: Adult; Aged; Altitude; Biomarkers; Dyslipidemias; Female; gamma-Glutamyltransferase; Hemoglobins; Hu | 2015 |
High uric acid level associated with increased arterial stiffness in apparently healthy women.
Topics: Adult; Aged; Alcohol Drinking; Ankle Brachial Index; Anthropometry; Asymptomatic Diseases; Blood Glu | 2014 |
[Insulin resistance and components of metabolic syndrome, analysis by gender and stage of adolescence].
Topics: Adipose Tissue; Adolescent; Age Factors; Blood Glucose; Body Mass Index; Child; Cholesterol; Dyslipi | 2014 |
The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China.
Topics: Adolescent; Adult; Aged; Ankle Brachial Index; Biomarkers; Blood Glucose; Blood Pressure; Cardiovasc | 2015 |
Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones.
Topics: Adolescent; Body Mass Index; Calcium; Case-Control Studies; Child; Child, Preschool; Citric Acid; Cr | 2015 |
The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study.
Topics: Aged; Cardiovascular Diseases; China; Cohort Studies; Coronary Disease; Dyslipidemias; Female; Human | 2015 |
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Blood Pressure; Body Mass Index; Cardiovascular Dise | 2015 |
Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders.
Topics: Animals; Biomarkers; Blood-Brain Barrier; Dyslipidemias; Gliosis; Glucose Tolerance Test; Humans; Hy | 2015 |
Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities.
Topics: Adult; Aged; Aged, 80 and over; China; Comorbidity; Dyslipidemias; Female; Humans; Hypertension; Hyp | 2016 |
Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China.
Topics: Adult; Age Factors; Aged; Body Mass Index; China; Diabetes Mellitus; Dyslipidemias; Female; Humans; | 2015 |
Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.
Topics: Age Factors; Aged; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Cholesterol, LDL; Comor | 2016 |
Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; China; Cholesterol, HDL; Cholesterol, LDL; | 2016 |
Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
Topics: Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood Urea Nitrogen; C-Reactiv | 2016 |
Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
Topics: Adolescent; Adult; Antineoplastic Agents; Biomarkers; Cancer Survivors; Cardiovascular Diseases; Cog | 2016 |
Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Calcitriol; Cross-Sectional Studies; Diabetes Mellitus; Diuretics; D | 2016 |
The association of uric acid with leukoaraiosis.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Asian People; Cognitive Dysfunction; Cross-Sectional Stud | 2017 |
Correlation of uric acid levels and parameters of metabolic syndrome.
Topics: Adult; Biomarkers; Cholesterol, HDL; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Male; M | 2017 |
Inflammatory status and uricaemia determine HDL-cholesterol levels in hypertensive adults over 65: an analysis of the FAPRES register.
Topics: Aged; Biomarkers; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studi | 2017 |
Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Dyslipidemias; Epidemiologic Methods; Fe | 2010 |
Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients.
Topics: Adiposity; Aged; Anthropometry; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Di | 2010 |
Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population.
Topics: Adult; Aged; Cardiovascular Diseases; China; Cross-Sectional Studies; Dyslipidemias; Ethnicity; Fema | 2009 |
The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; | 2010 |
Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students.
Topics: Adolescent; Asian People; Dyslipidemias; Female; Heart Diseases; Humans; Hypertension; Male; Metabol | 2010 |
Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.
Topics: Adult; Biomarkers; Blood Pressure; California; Cross-Sectional Studies; Dyslipidemias; Fatty Liver; | 2010 |
Uric acid levels predict future development of chronic kidney disease.
Topics: Aged; Body Mass Index; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Ch | 2011 |
Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme.
Topics: Adult; Alcohol Drinking; Biomarkers; Body Mass Index; Brazil; Cardiovascular Diseases; Cross-Section | 2011 |
Altered serum selenium and uric acid levels and dyslipidemia in hemodialysis patients could be associated with enhanced cardiovascular risk.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Dyslipidemias; Female; Humans; Kidney Failure, Chro | 2011 |
Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus, Type 2; Dyslipidemias; Fema | 2011 |
Determinants of blood uric acid levels in a dyslipidemic Arab population.
Topics: Adult; Arabs; Body Mass Index; Chi-Square Distribution; Coronary Artery Disease; Cross-Sectional Stu | 2012 |
Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats.
Topics: Allopurinol; Animals; Blotting, Western; Carrier Proteins; Cholesterol; Creatinine; Dyslipidemias; F | 2012 |
[Characteristics of carbohydrate metabolism changes in elderly patients with gout and metabolic syndrome].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Carbohydrate Metabolism; Dyslipidemias; | 2012 |
Metabolic syndrome and urinary stone composition: what factors matter most?
Topics: Adult; Aged; Calcium Oxalate; Calcium Phosphates; Diabetes Complications; Dyslipidemias; Female; Hum | 2012 |
Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".
Topics: Adult; Atherosclerosis; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Humans; India | 2013 |
[Metabolic and anthropometric profile of Aruák Indians: Mehináku, Waurá and Yawalapití in the Upper Xingu, Central Brazil, 2000-2002].
Topics: Adult; Anthropometry; Body Constitution; Brazil; Chronic Disease; Dyslipidemias; Female; Humans; Hyp | 2007 |
Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen.
Topics: Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Dyslipidemias; Employ | 2007 |
Comparison of serum uric acid levels between Japanese with and without metabolic syndrome.
Topics: Abdominal Fat; Adult; Aged; Alcohol Drinking; Asian People; Dyslipidemias; Female; Humans; Male; Met | 2008 |
Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Dyslipidemias; Follow-Up Studies; | 2008 |